New patent expiration for Boehringer Ingelheim drug SPIRIVA RESPIMAT

Annual Drug Patent Expirations for SPIRIVA+RESPIMAT Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are nineteen… The post New patent expiration for Boehringer Ingelheim drug SPIRIVA RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: